Prophylactic cholecystectomy in midgut carcinoid patients

Area of Science:

• Gastroenterology
• Oncology
• Surgical Oncology

Background:

• Midgut carcinoid (MGC) tumors are often treated with somatostatin analogs.
• These analogs can cause gallbladder dysfunction, gallstones, and cholecystitis.
• Prophylactic cholecystectomy is considered but lacks strong supporting data.

Purpose of the Study:

• To analyze the risk of gallstone formation and complications in MGC patients.
• To evaluate the necessity of prophylactic cholecystectomy in MGC patients treated with somatostatin analogs.

Main Methods:

• Retrospective analysis of 235 MGC patients.
• Examined cholecystectomy history and somatostatin analog treatment.
• Assessed gallstone-related complications and findings from imaging studies.

Main Results:

• 22/144 patients on somatostatin analogs developed gallstone complications.
• 63% of examined patients on somatostatin analogs had gallstones.
• Only 3/43 patients not on somatostatin analogs experienced biliary colic.

Conclusions:

• Gallstone complication incidence is higher in MGC patients on somatostatin analogs than in the general population.
• Liberal prophylactic cholecystectomy is recommended during MGC surgery for patients receiving somatostatin analogs.